Search results

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 13 November 2020

SPC updated with additional indication - for the first-line maintenance treatment of homologous recombination deficiency (HRD)-positive advanced ovarian cancer in combination with bevacizumab.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 13 November 2020

SPC –details license extension for use in symptomatic chronic heart failure with reduced ejection fraction in adults. Dapagliflozin has not been studied for the treatment of heart failure in pts with...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 13 November 2020

SPC advises that sildenafil should not be used in neonates with persistent pulmonary hypertension of the newborn as risks outweigh the benefits. The safety and efficacy of sildenafil in other...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 13 November 2020

SPC warns of risk of serotonin syndrome when co-administered with selective serotonin reuptake inhibitors/serotonin norepinephrine re-uptake inhibitors. If concomitant treatment is required, careful...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 29 October 2020

Following PRAC recommendation, SPCs now include warning that concomitant administration with other serotonergic agents, such SSRIs, SNRIs) or tricyclic antidepressants may result in serotonin...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 29 October 2020

SPCs now advise that patients must be instructed to perform continuous rotation of the injection site to reduce the risk of developing lipodystrophy and cutaneous amyloidosis, which can lead to...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 29 October 2020

Myoclonus has been added to SPC as an adverse event of unknown frequency. The SPC has also been updated to advise that in postmarketing experience, there have been reports of intentional overdose of...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 04 November 2020

SPC now warns that symptomatic hypophosphataemia leading to osteomalacia and fractures requiring clinical intervention including surgery has been reported in the post marketing setting. Patients...

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 04 November 2020

Restless legs syndrome has been added to SPC as adverse effect.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 04 November 2020

Insomnia and alopecia (frequency “common”) and reduced visual acuity (frequency “not known”) have been to SPC as adverse effects.

Read Summary

Type:

Prescribing and Technical Information (Add filter)

Type:

Medicines Current Awareness (Remove filter)